The world health organization (who) has temporarily suspended trials of hydroxychloroquine and chloroquine as a cure for coronavirus

I, Yann /

“This applies only to the use of hydroxychloroquine and chloroquine for the treatment of COVID-19 – added Ghebreyesus. – Other stages of testing continues”

The world health organization

The world health organization (who) has temporarily suspended trials of antimalarial drugs hydroxychloroquine and chloroquine as a drug of coronavirus. This was stated Monday at a briefing, who Director-General Tedros Adan Ghebreyesus, quoted by TASS.

Recently in the medical journal Lancet published a study of hydroxychloroquine and chloroquine and their effect on hospitalized with COVID-19 patients. The authors also argue that among the patients taking these medications alone or in combination with a macrolide antibiotic, recorded a higher mortality rate.

96 after analyzing the data of thousands of patients of the 671 hospitals worldwide, scientists have come to the conclusion that chloroquine and its derivative, gidroksihlorohina potentially dangerous because it can cause complications of the cardiovascular system. The likelihood of cardiac arrhythmia from taking an antimalarial drug was significantly increased.

The researchers compared the data of patients in the three groups. The first data were collected of patients who were treated with one of drugs against malaria, the second data of patients who were given an antimalarial drug in combination with an antibiotic. The third group – the control group consisted of patients in whom chloroquine and hydroxychloroquine were not given.

Mortality in the control group amounted to 9.3%, the mortality rate in the group who took medication, from 16 to 23.8% (in the group receiving hydroxychloroquine, and 18%; in the group taking chloroquine to 16.4% in the group taking medications and antibiotics to 22.2% and 23.8%).

Of ghebreyesus stressed that the suspension applies only to the use of hydroxychloroquine and chloroquine for the treatment of COVID-19. Other stages of testing are ongoing. The head of the who also added that these drugs continue to be safe for patients with autoimmune diseases and malaria.

Media: now hopes are pinned only on one medicine for coronavirus

In turn, the chief researcher who Soumya Swaminathan said that the decision “will be revised within the next two weeks.” “We have to be careful and to suspend study of hydroxychloroquine, she said. – We plan to review these studies and in parallel continue to gather information about the effectiveness of hydroxychloroquine”.

For his part, the Director of the who programme on emergency health Michael Ryan noticed that this situation does not undermine the research. “The idea is to analyze incoming information,” he said.

Ryan also said that the pandemic coronavirus at the global level still progresses, and urged all countries to be ready for a second wave of disease, to comply with security measures to track spread of coronavirus and to carry out testing. According to him, the second wave incidence can be the same as the seasonal flu epidemic.

At the same time in the least degree from the coronavirus was injured African. As noted by the head of the who in Africa at the moment, recorded only 1.5% of the total number of cases and less than 0.1% of the total number of deaths in the world. However, according to him, these figures do not give a complete picture since some cases were not registered.

In April, the office for the quality of the food and drug administration Department of health and human services, the United States warned compatriots from the use of hydroxychloroquine out of hospitals due to side effects such as possible problems with the cardiovascular system. A number of studies have proven the ineffectiveness of this drug in the treatment of coronavirus, and several people died in USA, deciding to treat them yourself at home.

At the end of March in Arizona, the man died, who took home the chloroquine phosphate, which a few decades is used against malaria, believing that this will protect it from infection by coronavirus. His wife was hospitalized and later told reporters that they watched the briefings, during which the US President Donald trump talked about the potential benefits of chloroquine. The President also admitted that taking the hydroxychloroquine, and daily testing for the presence of coronavirus infection while give a negative result. Doctor President Sean Conley stated that the potential benefits of this treatment exceed the relative risks.

The Ministry of health of Brazil also stated that it will not change its recommendation to treat the coronavirus with hydroxychloroquine, despite the decision of the world health organization. Like Donald trump, the President of Brazil, Jar of Bolsonaro “advertised” the perceived benefits of hydroxychloroquine and chloroquine against the new coronavirus.

“We remain calm, and in the Brazilian guide, published last week, will not change. This was not a clinical trial, it was just a set of data collected from different countries, and he did not meet the criteria for methodologically acceptable studies, which can serve as a reference for any country in the world, including Brazil,” – said at a press conference, the official of the Ministry of health Mayra Pinheiro. Her words quoted Medikforum. On the use of hydroxychloroquine in the treatment of patients also said the Ministry of health of Turkey.